Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The 14th signing for this quarter

I think that may be true, but I'm still interpreting they book the numbers based on the signing, not when cash is tranferred to their account. Which may account for the difference in cash on hand and sales, etc etc. So we may see a higher number for sales in this quarter than actual cash received, but our EPS will be based on the sales not he cash on hand number anyway and that will still influence our highest EPS per quarter ever. That's what the investment guys will look at, the booked slaes for EPS calculation rather than the actual cash in the bank at the end of the quarter.

If that is so we should show in our "Receivables" what has been signed for and not paid to us as of the 29th. JMHO

 

Share
New Message
Please login to post a reply